<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Life Sciences: The Real, the Hoped, and the Hyped</title>
  <description>Drug development platforms such as mRNA, CRISPR, and gene therapies combined with cost-effective development are creating spectacular economic opportunities. New firms are targeting large markets including treatments for cancer, auto-immune disease, and other pathologies of the immune system, the brain, and infectious diseases. </description>
  <author_name>Investment Principles and Strategies' podcast</author_name>
  <author_url>https://arcadiacapitalgroup.com/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/20872907/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/126473744</thumbnail_url>
</oembed>
